A Multi-center, Double-blind, Placebo-Controlled Study of Paroxetine and Imipramine in Adolescents with Unipolar Major Depression - Acute Phase
Depressive Disorder
Phase 3
This study has multiple results summaries on the GSK Clinical Study Register under the following clinical study identifiers: BRL-029060/329: Acute Phase and BRL-029060/329 - continuation. This posting links only to BRL-029060/329: Acute Phase. All other results summaries must be viewed directly from the GSK Clinical Study Register. A link to and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies. Due to the age of this study, the annotated case report form is not available. A blank case report form will be provided. The data from this study is provided in combined datasets containing data from other paroxetine studies. This record was formally under the ID: BRL-029060/329: Acute Phase.
January 2014